Top 10 Leading Companies In Peripheral Vascular Devices Market

Boston Scientific Corporation (US) Boston Scientific Corporation accounted for the second-largest share of the global peripheral vascular devices. The company provides its robust portfolio of peripheral vascular devices and efforts to develop innovative products by investing in R&D.

Peripheral Vascular Devices Market Trends:

The global peripheral vascular devices market size is projected to reach USD  13.4 billion by 2026 from USD  10.3 billion in 2021, at a CAGR of 5.3%  from 2021 to 2026. The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.

Get Sample PDF: https://www.marketsandmarkets.com/requestsampleNew.asp?id=790

Key Market Players of Peripheral Vascular Devices Market:

Medtronic (Ireland), Boston Scientific Corporation (US). In 2021, Medtronic (Ireland), held the leading position in the market. The company has a strong geographic presence across North America, Europe, and Asia Pacific. Boston Scientific Corporation (US) held the second position in the peripheral vascular devices market

Medtronic (Ireland) held the leading position in the peripheral vascular devices market in 2020. The company offers an exhaustive product portfolio consisting of various peripheral vascular devices. The company’s strong heritage of technology, leadership, and innovation has provided a solid foundation for the continued development of safe and cost-effective products.

COVID -19 IMPACT ON PERIPHERAL VASCULAR DEVICES MARKET.

Globally, a majority of countries have postponed elective surgeries in order to prevent the spread of COVID-19. Since 70–80% of peripheral vascular interventional procedures are elective, many of these procedures have been postponed. This is another factor negatively impacting the growth of the peripheral vascular devices market. For instance, as per Medtronic’s financial 2021, Aortic, Peripheral Venous, second-quarter revenue of USD 468 million is by decreased 1.3 % and 1.9 %

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790

Emerging markets, such as China, India, Singapore, and Brazil, are expected to witness high growth in the coming years owing to the presence of less-stringent regulatory policies and low competition. In order to leverage the high-growth opportunities in these markets, manufacturers are strategically focusing on expanding their presence in these countries. Moreover, the increasing competition in mature markets is further compelling manufacturers to focus on emerging markets. Medtronic (Ireland) opened its Asia Pacific regional headquarters in Singapore. This development will support and strengthen the company’s operations in 80 locations across the Asia Pacific region.

Recent Developments:

  • Medtronic received the US FDA approval for its IN. PACT AV drug-coated balloon (DCB) to treat arteriovenous fistula lesions
  • Boston Scientific Corporation received the FDA Approval for its VICI VENOUS STENT System for treating patients with deep venous blockages.

Speak to our analyst for a discussion on the above findings: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=790

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com


johnny andrew

4 Blog posts

Comments